Asthma
COPD
Pulmonary
Search
Article
Blog
Company
Podcast
Product
Video
Whitepaper
Enter search phrase
Search
Type: Article
Home
Mast cells emerge as central drivers of allergic asthma
Research suggests that suppressing mast cell activity may prevent many hallmark features of allergic asthma.
October 1, 2026
Asthma
Triple versus dual inhaler therapy for asthma control
Benefits extend to reduced exacerbations, fewer oral corticosteroids and improved lung function.
October 1, 2026
Pulmonary
ERS publishes updated PAH guidelines
The revised recommendations add sotatercept and provide an evidence-based framework for managing patients with pulmonary arterial hypertension.
October 1, 2026
COPD
Influenza vaccine may help lower flu-related hospitalizations in COPD patients
Novel study design finds reduced risk of hospitalization, but confounding factors may be an issue.
September 30, 2026
COPD
Ensifentrine shows promise treating pulmonary hypertension in COPD patients
Research finds nebulized ensifentrine was associated with modest but consistent improvements over six months in patients with severe COPD-associated pulmonary hypertension.
September 30, 2026
Pulmonary
Protein-based MRI agent aids early lung cancer diagnosis
The targeted, noninvasive technology detects abnormal collagen development in lung tumors and metastatic lesions.
September 25, 2026
Pulmonary
MRI reduces cognitive failure, adverse events in SCLC
Analysis supports MRI surveillance alone, rather than preventive brain radiation, as the standard of care approach for patients with small-cell lung cancer.
September 24, 2026
Asthma
Is there a ‘window of opportunity’ for biologic treatment in severe asthma?
AI, biologic biomarkers and digital health tools that evaluate treatment timing could help prevent irreversible airway damage.
September 24, 2026
Asthma
Semaglutide significantly lowers asthma, COPD attacks
Scientific community should consider metabolic health as part of future respiratory therapies.
September 24, 2026
COPD
Research aims to develop better tools for dyspnea detection
University of California researcher to launch five-year project to better understand dyspnea in COPD patients.
September 23, 2026
COPD
Novel inhaled treatment for COPD shows promise in clinical trial
Metered spray treatment demonstrated clinically meaningful improvements in quality of life and COPD symptoms.
September 23, 2026
Pulmonary
Common cold: There may be a vaccine for that
Early clinical trial results demonstrate safety and efficacy in preventing rhinovirus-related COPD and asthma exacerbations.
September 18, 2026
Pulmonary
Inpatient PAH therapy transition deemed safe
Research supports concurrent switch from infusion treatment to oral medication over a closely monitored, continuous timeframe averaging 36 hours.
September 17, 2026
COPD
FDA approves study of inhaled stem cell therapy for COPD
The investigational drug is scheduled for a phase 1b trial in late 2026.
September 17, 2026
COPD
Childhood pollution exposure linked to COPD
Children with a higher genetic risk showed reduced lung development but only when exposed to pollution.
September 17, 2026
Asthma
Experimental bacterial extract fails to prevent pediatric wheezing or asthma
Common childhood illnesses, such as fevers, coughs and colds, occurred at similar rates in drug and placebo groups.
September 17, 2026
Asthma
Tiotropium safe for preschool asthma but not more effective
German researchers evaluated benefits of the inhaled muscle relaxant in preschool-aged children
with severe asthma.
September 17, 2026
Pulmonary
Foretelling the future of lung cancer recurrence
Researchers have discovered multiple noninvasive ways to predict risk and improve outcomes.
September 11, 2026
Previous Page
Next Page